Multimedics

Interventional Cardiology Devicesmultimedicsllc.com

Multimedics LLP is an India-based medical device manufacturer founded in 2009, producing drug-eluting coronary stents and balloon catheters for hospitals and cardiac catheterization laboratories across 23 countries. Its portfolio is built on a 59µm cobalt chromium L605 platform with biodegradable PLLA/PLGA polymer and Sirolimus/Everolimus drug coatings.

Company typePrivate
Founded2009
HeadquartersAhmedabad, India
Headcount11–50
GTM typeB2B
OfferingHardware or Manufacturing

What Multimedics does

Multimedics LLP is an India-based, privately held medical device manufacturer founded in 2009 and headquartered in Baddi, Himachal Pradesh (with secondary Ahmedabad listing). The company specializes in interventional cardiology and cardiac care, producing drug-eluting coronary stents (DES) and balloon catheters for hospitals and cardiac catheterization laboratories across 23 countries. Its portfolio includes bare-metal stents (M'Sure, M'Sure-Cr), Sirolimus and Everolimus drug-eluting stents (M'Sure-S, MyStent-S, Tapper-S, Eliminator), and semi-compliant and non-compliant balloon catheters (Ruby SC, Ruby NC).

The company's core technology centres on a cobalt chromium L605 platform with an ultra-low 59µm strut thickness, electro-polishing finishing, and a biodegradable PLLA/PLGA polymer base designed to elute simultaneously with low-dose Sirolimus or Everolimus (1.00-1.30 µg/mm²) over a 30-45 day window. The 99-SKU M'Sure-S range covers 2.00-5.00mm diameters and 8-48mm lengths, supporting lesion variability. Clinical claims rest on the PRISM program (Pilot, Subcontinental, Euro-PRISM, Global) covering 100,000+ patients. Manufacturing runs under cGMP and ISO 13485:2016 at a single Baddi facility.

Multimedics generates revenue through direct hospital sales and distribution partnerships, with claims of deploying 2+ stents per hour globally and 100,000+ patients treated cumulatively. Pricing is quote-based through hospital procurement rather than publicly disclosed, and the company holds CE marking (claimed pioneer for DES with biodegradable polymers via DNV), DCGI, and ISO 13485 certifications. The operating model is enterprise field sales targeting interventional cardiology departments in cath-lab-equipped hospitals, with marketing concentrated on cardiology conferences (Euro PCR, TCT) and clinical publications. The firm is small (11-50 employees), has no disclosed external funding, and operates as a private LLP without a parent company.

Multimedics firmographics

Firmographics

Name: Multimedics
Legal name: Multimedics LLP
Website: https://multimedicsllc.com
Company type: Private
Founded year: 2009
Operating status: Operating
Headcount range: 11–50 employees
Short description: Multimedics LLP is an India-based medical device manufacturer founded in 2009, producing drug-eluting coronary stents and balloon catheters for hospitals and cardiac catheterization laboratories across 23 countries. Its portfolio is built on a 59µm cobalt chromium L605 platform with biodegradable PLLA/PLGA polymer and Sirolimus/Everolimus drug coatings.
Ownership category
akta.pro rank

Multimedics industry classification

Industry

Product category: Interventional Cardiology Devices
NAICS: Surgical and Medical Instrument Manufacturing (339112)
SIC: Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry: Coronary Stents & Drug-Eluting Technologies (HLAHAFAA)

Keywords

Drug-eluting stents
Coronary stents
Balloon catheters
Interventional cardiology
Cardiac care devices

Where Multimedics is headquartered

Location

Headquarters

HQ city: Ahmedabad
HQ country: India
HQ region: Asia

Offices2 records

Markets served

Multimedics business model

Business model

GTM type: B2B
Offering type: Hardware or Manufacturing
Cost components: Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure

Revenue model

Coronary Stent Sales: Sale of drug-eluting coronary stents including M'Sure, M'Sure-S, M'Sure-Cr, MyStent-S, Tapper-S, and Eliminator models to hospitals and cardiac care centers globally
Balloon Catheter Sales: Sale of semi-compliant (Ruby SC) and non-compliant (Ruby NC) balloon catheters for interventional procedures

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Multimedics product offering

Product offering

Core offering

Multimedics manufactures and supplies interventional cardiology devices, including bare-metal and drug-eluting coronary stents and semi-compliant and non-compliant balloon catheters. The company serves hospitals and cardiac catheterization laboratories globally.

Product overview

Multimedics is a medical device company specializing in interventional cardiology and cardiac care products. The company offers a comprehensive portfolio of coronary stents and balloon catheters. The stent portfolio includes bare metal stents (M'Sure in stainless steel and M'Sure-Cr in cobalt chromium) and drug-eluting stents (M'Sure-S, MyStent-S, Tapper-S with Sirolimus, and Eliminator with Everolimus). The balloon catheter lineup comprises semi-compliant (Ruby SC) and non-compliant (Ruby NC) balloons for pre-dilatation, post-dilatation, and lesion preparation. All products are manufactured in ISO 13485:2016 compliant facilities and carry CE marking for global distribution.

Differentiator

Problem solved

Functional benefit

Brands

M'Sure: Stainless steel (SS316L) bare metal coronary stent, laser cut from seamless tubing in a serpentine pattern.
M'Sure - S
M'Sure - Cr
MyStent - S
Eliminator
Tapper-S
Ruby
Ruby NC

Products and services

Bare-metal coronary stents Coronary stents without drug coating, used in interventional cardiology procedures to maintain vessel patency. Designed for hospitals and cardiac catheterization laboratories.
Drug-eluting coronary stents Coronary stents with biodegradable polymer coating for controlled drug elution, used to reduce restenosis in interventional cardiology procedures. Targeted at hospitals and cath labs.
Semi-compliant balloon catheters Balloon catheters designed for predictable expansion during percutaneous coronary interventions, used in pre-dilation and stent deployment in hospitals and cath labs.
Non-compliant balloon catheters High-pressure balloon catheters engineered for post-dilation and resistant lesion treatment in interventional cardiology, serving hospitals and cardiac catheterization laboratories.

Quantifiable outcome

Ultra-low strut thickness of 59µm for all diameters
+3 more outcomes

Companies that use Multimedics

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Multimedics technology and API

Technology

Technology focussed Yes

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Multimedics partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Multimedics competitors and assessment

Company assessment

Broad incumbents

Abbott Laboratories: Owner of the Xience DES franchise (Xience Sierra, Xience Skypoint), the global gold-standard DES. Competes with Multimedics across all 23 countries it serves and sets the technology benchmark for strut thickness and deliverability.
B. Braun: German medical device and interventional cardiology player with the Coroflex ISAR DES and SeQuent Please drug-coated balloon. Comparable as an established European DES/balloon manufacturer competing for the same hospital formularies.
Medtronic: Manufacturer of Resolute Onyx and Endeavor DES platforms. Competes directly with Multimedics in the global coronary stent market and has far greater commercial and clinical-trial resources.
Boston Scientific: Global interventional cardiology leader whose Synergy bioabsorbable polymer DES and Promus Element platforms compete head-to-head with Multimedics' M'Sure-S and Eliminator in CE-marked markets.
Terumo Corporation: Japanese medical device company with a strong interventional cardiology portfolio (Ultimaster DES, Ryusei balloon) and global distribution. Competes with Multimedics in EMEA and Asia catheter lab accounts.

Direct peers

Translumina Therapeutics: India- and Germany-based DES manufacturer offering sirolimus- and biolimus-eluting stents (Yukon, Custom NX) with CE marking. Direct peer in the European-focused biodegradable-polymer DES segment.
Meril Life Sciences: India-based interventional cardiology manufacturer producing drug-eluting stents (MyVal, BioMime) and balloon catheters. Most direct comparable due to shared Indian manufacturing base, similar DES+balloon portfolio, and global emerging-market commercial strategy.
Lepu Medical: China-based manufacturer of coronary stents (Nano+, Partner) and balloon catheters with CE marking. Comparable as a non-Western DES challenger competing on cost in emerging markets.
MicroPort Scientific: Chinese medical device company with an interventional cardiology division (Firehawk DES, FOXTROT NC balloon) and global commercial reach. Comparable in product breadth and emerging-market positioning.
Sahajanand Medical Technologies (SMT): Indian manufacturer of coronary stents (Supraflex, Yukon Choice) and balloon catheters with strong presence in EMEA, Latin America, and Asia. Closest head-to-head competitor for Multimedics given similar product mix, pricing tier, and emerging-market focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Multimedics compliance and trust

Trust signal

Compliance4 records

Multimedics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Multimedics leadership team

Management profile

Number of profiles

Multimedics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Multimedics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Multimedics

What does Multimedics do?

Is Multimedics a public or private company?

Multimedics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Multimedics founded?

Multimedics was founded in 2009. It employs 11 to 50 people.

Where is Multimedics based?

Multimedics is headquartered in Ahmedabad, India, in the Asia region.

How does Multimedics make money?

Two revenue lines are on record. Coronary Stent Sales are the primary driver. The others are balloon Catheter Sales.

Who are Multimedics's main competitors?

Broad incumbents on record are Abbott Laboratories, B. Braun, Medtronic, Boston Scientific and Terumo Corporation. Direct peers are Translumina Therapeutics, Meril Life Sciences, Lepu Medical, MicroPort Scientific and Sahajanand Medical Technologies (SMT).

Does Multimedics have an API?

No public API is recorded for Multimedics.

What industry is Multimedics in?

Multimedics's product category is Interventional Cardiology Devices. Its primary akta.pro industry code is HLAHAFAA, Coronary Stents & Drug-Eluting Technologies. Its NAICS code is 339112 and its SIC code is 3841.